Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

TRVI

Trevi Therapeutics (TRVI)

Trevi Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TRVI
일자시간출처헤드라인심볼기업
2024/05/0920:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming ConferencesNASDAQ:TRVITrevi Therapeutics Inc
2024/05/0805:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRVITrevi Therapeutics Inc
2024/05/0805:05PR Newswire (US)Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
2024/05/0205:05PR Newswire (US)Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024NASDAQ:TRVITrevi Therapeutics Inc
2024/04/2320:30Business WireFNB Harvest annonce les distributions d’avril 2024NASDAQ:TRVITrevi Therapeutics Inc
2024/04/0920:30PR Newswire (US)Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International ConferenceNASDAQ:TRVITrevi Therapeutics Inc
2024/04/0420:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming April EventsNASDAQ:TRVITrevi Therapeutics Inc
2024/04/0220:30PR Newswire (US)Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership TeamNASDAQ:TRVITrevi Therapeutics Inc
2024/03/2120:30Business WireFNB Harvest annonce les distributions de mars 2024NASDAQ:TRVITrevi Therapeutics Inc
2024/03/2105:05PR Newswire (US)Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
2024/03/1405:05PR Newswire (US)Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024NASDAQ:TRVITrevi Therapeutics Inc
2024/02/2821:30PR Newswire (US)Trevi Therapeutics to Participate in Upcoming March EventsNASDAQ:TRVITrevi Therapeutics Inc
2024/02/2221:30Business WireFNB Harvest annonce les distributions de février 2024NASDAQ:TRVITrevi Therapeutics Inc
2024/02/1706:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
2024/02/1706:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
2024/02/1706:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVITrevi Therapeutics Inc
2024/02/1510:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRVITrevi Therapeutics Inc
2024/02/1505:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRVITrevi Therapeutics Inc
2024/02/0621:30PR Newswire (US)Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:TRVITrevi Therapeutics Inc
2024/01/2421:30Business WireFNB Harvest annonce les distributions de janvier 2024NASDAQ:TRVITrevi Therapeutics Inc
2024/01/0421:30PR Newswire (US)Trevi Therapeutics Provides Business UpdatesNASDAQ:TRVITrevi Therapeutics Inc
2023/12/3000:26Business WireFNB Harvest annonce les distributions annuelles finales réinvesties pour 2023NASDAQ:TRVITrevi Therapeutics Inc
2023/12/2206:33Business WireFNB Harvest Distributions réinvesties annuelles estimatives révisées pour 2023NASDAQ:TRVITrevi Therapeutics Inc
2023/12/1821:30Business WireFNB Harvest annonce les distributions de décembre 2023NASDAQ:TRVITrevi Therapeutics Inc
2023/12/0521:30PR Newswire (US)Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:TRVITrevi Therapeutics Inc
2023/12/0105:14Business WireFNB Harvest Distributions réinvesties annuelles estimées pour 2023NASDAQ:TRVITrevi Therapeutics Inc
2023/11/1721:30Business WireFNB Harvest annonce les distributions de novembre 2023NASDAQ:TRVITrevi Therapeutics Inc
2023/11/1006:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRVITrevi Therapeutics Inc
2023/11/1006:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRVITrevi Therapeutics Inc
2023/11/1006:05PR Newswire (US)Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TRVITrevi Therapeutics Inc
 검색 관련기사 보기:NASDAQ:TRVI